Exploring Viral Clearance for AAV Products: A Study of Detergent Lysis and Chromatography Steps
Shaping the Future of Medicine Through Cell and Gene Therapy Innovation
What Does 2025 Hold For Biopharma? Part 1: The State Of The Biopharma Industry
Maintaining Momentum with OXB’s CEO, Dr. Frank Mathias
Conquering the Complexities of AAV Manufacturing: Advances in Efficiency, Scalability, Compliance
Lentiviral Vector Determinants of Anion‐Exchange Chromatography Elution Heterogeneity
Membrane Adsorber Design for Lentiviral Vector Recovery
Webinar: How to Optimize AAV Potency through Effective Formulation Strategies
Annual General Meeting 2025: Questions and Answers
20 June 2025
AAV: inAAVate™ Platform Infographic
OXB Investor Presentation June 2025
3 June 2025
Presentation: Accelerate Time to Clinic- A Platform and Analytics Approach
